Translumina Therapeutics reposted this
We are excited to share that Prof. (Dr.) Florim Cuculi, a distinguished Interventional Cardiologist and Head of Cardiology at Heart Centre Lucerne, recently achieved an excellent outcome using the Protégé Drug-Coated Balloon in a highly complex case . The patient presented with severely calcified, small vessel, CTO, bifurcation & long diffuse lesion, showcasing the power of this innovative technology in treating challenging coronary interventions. DCBs are revolutionizing the treatment of complex coronary interventions by offering a significant advantage over traditional drug-eluting stents delivering improved luminal gain without the need for stent implantation. Preliminary data shows promising results, and this successful case reinforces the effectiveness of Protégé NC DCB in treating complex lesions. A heartfelt thank you to Florim Cuculi for sharing his expertise and invaluable contribution to this success. We are thrilled to announce that #ProtégéDCB is now available in Switzerland✨️✨️ #Translumina #ModernPCI #InterventionalCardiology #ComplexPCI
Several factors make stent implantation unattractive in this situation: chronic total occlusion, 1:1:1 bifurcation, calcifications, small diameter (< 3.0 mm) and very long lesion. After crossing with a Gaia 2 wire, wolverine cutting balloon was used in the LAD & Diagonal. Protégé NC paclitaxel coated balloon was applied to LAD and Diagonal achieving a great angiographic and OCT result. The presence of a media dissection indicates luminal gain in the near future. Protégé NC has an excellent profile and is a great choice to treat complex lesions. We will soon launch a new trial focussing on the efficacy of Protégé in complex coronary lesions. TransluminaTranslumina TherapeuticsGurmit Singh ChughAjay TambeDr.Nancy ChughThomas Kraft, PhD.Matthias BossardAdrian Attinger-TollerAdnan Kastrati
Regional Sales Manager, Translumina
2wImpressive